Free Trial

Charles River Laboratories International (CRL) Earnings Date, Estimates & Call Transcripts

$214.51
-2.70 (-1.24%)
(As of 05/28/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 14Estimated
Actual EPS
(May. 9)
$2.27 Beat By $0.22
Consensus EPS
(May. 9)
$2.05
Skip Charts & View Estimated and Actual Earnings Data

CRL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Charles River Laboratories International Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$2.05$2.73$2.39 
Q2 20242$2.63$2.68$2.66 
Q3 20242$3.02$3.09$3.06 
Q4 20242$3.21$3.37$3.29 
FY 20248$10.91$11.87$11.39 
Q1 20252$2.69$2.92$2.81 
Q2 20251$2.98$2.98$2.98 
Q3 20252$3.11$3.21$3.16 
Q4 20252$3.33$3.59$3.46 
FY 20257$12.11$12.70 $12.41

CRL Earnings Date and Information

Charles River Laboratories International last released its earnings results on May 9th, 2024. The medical research company reported $2.27 earnings per share for the quarter, beating analysts' consensus estimates of $2.05 by $0.22. The firm had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $997.24 million. Charles River Laboratories International has generated $8.50 earnings per share over the last year ($8.50 diluted earnings per share) and currently has a price-to-earnings ratio of 25.2. Earnings for Charles River Laboratories International are expected to grow by 12.00% in the coming year, from $11.00 to $12.32 per share. Charles River Laboratories International has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.

Charles River Laboratories International Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/14/2024
(Estimated)
------- 
5/9/2024Q1 2024$2.05$2.27+$0.22$3.24$997.24 million$1.01 billion    
2/14/2024Q4 2023$2.39$2.46+$0.07$1.30$991.25 million$1.01 billion      
11/8/2023Q3 2023$2.35$2.72+$0.37$3.75$1.00 billion$1.03 billion      
8/9/2023Q2 2023$2.63$2.69+$0.06$3.49$1.05 billion$1.06 billion      
5/11/2023Q1 2023$2.59$2.78+$0.19$3.55$988.10 million$1.03 billion
2/22/2023Q4 2022$2.75$2.98+$0.23$2.31$1.04 billion$1.10 billion      
11/2/2022Q3 2022$2.51$2.63+$0.12$3.38$978.65 million$989.16 million
8/3/2022Q2 2022$2.74$2.77+$0.03$3.41$995.12 million$973.13 million    
5/4/2022Q1 2022$2.71$2.75+$0.04$3.69$908.64 million$913.93 million      
2/16/2022Q4 2021$2.42$2.49+$0.07$2.31$888.27 million$905.05 million    
11/2/2021Q3 2021$2.58$2.70+$0.12$3.39$902.03 million$895.90 million    
8/3/2021Q2 2021$2.38$2.61+$0.23$3.50$880.72 million$914.61 million    
5/3/2021Q1 2021$2.19$2.53+$0.34$3.86$798.52 million$824.60 million  
2/16/2021Q4 2020$2.11$2.39+$0.28$1.97$755.98 million$790.99 million  
10/29/2020Q3 2020$1.80$2.33+$0.53$2.63$715.63 million$743.30 million    
8/5/2020Q2 2020$1.27$1.58+$0.31$1.82$638.70 million$682.60 million    
5/7/2020Q1 2020$1.46$1.84+$0.38$2.66$692.11 million$707.06 million    
2/11/2020Q4 2019$1.83$2.01+$0.18$2.41$685.46 million$691.10 million    
11/6/2019Q3 2019$1.64$1.69+$0.05$1.92$674.08 million$668.00 million    
7/31/2019Q2$1.55$1.63+$0.08$2.38$662.61 million$657.60 million  

Charles River Laboratories International Earnings - Frequently Asked Questions

When is Charles River Laboratories International's earnings date?

Charles River Laboratories International has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on CRL's earnings history.

Did Charles River Laboratories International beat their earnings estimates last quarter?

In the previous quarter, Charles River Laboratories International (NYSE:CRL) reported $2.27 earnings per share (EPS) to beat the analysts' consensus estimate of $2.05 by $0.22. Learn more on analysts' earnings estimate vs. CRL's actual earnings.

How can I listen to Charles River Laboratories International's earnings conference call?

The conference call for Charles River Laboratories International's latest earnings report can be listened to online. Listen to Conference Call

How can I read Charles River Laboratories International's conference call transcript?

The conference call transcript for Charles River Laboratories International's latest earnings report can be read online. Read Transcript

How much revenue does Charles River Laboratories International generate each year?

Charles River Laboratories International (NYSE:CRL) has a recorded annual revenue of $4.13 billion.

How much profit does Charles River Laboratories International generate each year?

Charles River Laboratories International (NYSE:CRL) has a recorded net income of $474.62 million. CRL has generated $8.50 earnings per share over the last four quarters.

What is Charles River Laboratories International's price-to-earnings ratio?

Charles River Laboratories International (NYSE:CRL) has a trailing price-to-earnings ratio of 25.24 and a forward price-to-earnings ratio of 19.50. The price/earnings-to-growth ratio is 2.06.

What is Charles River Laboratories International's EPS forecast for next year?

Charles River Laboratories International's earnings are expected to grow from $11.00 per share to $12.32 per share in the next year, which is a 12.00% increase.


More Earnings Resources from MarketBeat

This page (NYSE:CRL) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners